Article
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Arteriosclerosis, thrombosis, and vascular biology - 1 Jul 2011
Hu Xinli, Atzler Dorothee, Xu Xin, Zhang Ping, Guo Haipeng, Lu Zhongbing, Fassett John, Schwedhelm Edzard, Böger Rainer H, Bache Robert J, Chen Yingjie
Abstract excerpt
OBJECTIVE: The objective of this study was to identify the role of dimethylarginine dimethylaminohydrolase-1 (DDAH1) in degrading the endogenous nitric oxide synthase inhibitors asymmetrical dimethylarginine (ADMA) and N(g)-monomethyl-L-arginine (L-NMMA). METHODS AND RESULTS: We generated a global-DDAH1 gene-deficient (DDAH1(-/-)) mouse strain to examine the role of DDAH1 in ADMA and l-NMMA degradation and the...
Topics
- Amidohydrolases
- Animals
- Arginine
- Blood Pressure
- Cardiovascular Diseases
- Cells, Cultured
- Endothelial Cells
- Enzyme Inhibitors
- Female
- Genotype
